Projects

Mgr. Iveta Zmetáková, PhD.

National

Finished
  • TArgetiNg Dna mEthylation by epigenetic editing and its implementation into personalised diagnostics and therapy of uveal Melanoma
    Program: SRDA
    Duration: 1. 8. 2018 – 31. 12. 2022
  • Molecular biomarkers of relapse in seminoma clinical stage I patients
    Program: Other projects
    Duration: 1. 10. 2019 – 21. 12. 2022
  • Turning cisplatin-resistant testiular germ cell tumors into a curable disease
    Program: SRDA
    Duration: 1. 8. 2018 – 31. 12. 2021
  • Expression analysis of miRNA genes regulating the biology of cancer stem cells in breast cancer patients
    Program: VEGA
    Duration: 1. 1. 2017 – 31. 12. 2020
  • Micro-RNA expression profiles for discrimination of endometrioid and serous types of endometrial cancer
    Program: Other projects
    Duration: 1. 12. 2018 – 31. 12. 2020
  • DNA methylation profiles in genes associated with breast cancer metasasising
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Histone modification and DNA methylation relationship in transcription silencing of cancer associated genes
    Program: VEGA
    Duration: 1. 1. 2013 – 31. 12. 2016
  • Implementation of methods for analysis of epigenetic changes in genes involved in epithelial-mesenchymal transition in breast cancer
    Program: VEGA
    Duration: 1. 1. 2014 – 31. 12. 2016
  • Identification of predictive epigenetic biomarkers in breast cancers
    Program: SRDA
    Duration: 1. 5. 2011 – 31. 8. 2014
  • Diagnostics of socially important disorders in Slovakia, based on modern biotechnologies
    Program: EU Structural Funds Research & Development
    Duration: 2. 11. 2010 – 31. 10. 2013
  • Diagnoses of Socially Important Diseases in Slovakia Based on Modern Biotechnologies.
    Program: EU Structural Funds Research & Development
    Duration: 1. 11. 2010 – 31. 10. 2013
  • Epigenetic inactivation of selected genes for growth, invazivity and metastasis regulation in breast cancers
    Program: VEGA
    Duration: 1. 1. 2010 – 31. 12. 2012
  • Implementation of histology and molecular-biology methods in the tumor heterogenity analysis
    Program: Intra-constitutional
    Duration: 1. 1. 2010 – 31. 12. 2010
Employees